New hope for Tough-to-Treat gynecologic cancers?
NCT ID NCT07424664
Summary
This study is testing a new two-drug combination for women with advanced cervical, vulvar, or vaginal cancer that has returned or spread. It aims to see if the treatment is safe and effective for up to 30 participants who have already tried standard therapies. The approach combines a drug that targets cancer cells directly with another that helps the immune system fight the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UTERINE CERVICAL NEOPLASMS, RECURRENT; UTERINE CERVICAL NEOPLASMS, METASTATIC; VULVAR NEOPLASMS; VAGINAL NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.